PortfoliosLab logoPortfoliosLab logo
LABU vs. HIBL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

LABU vs. HIBL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bull 3x Shares (LABU) and Direxion Daily S&P 500 High Beta Bull 3X Shares (HIBL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LABU achieves a 3.80% return, which is significantly lower than HIBL's 96.27% return.


LABU

1D
4.61%
1M
-11.09%
YTD
3.80%
6M
3.63%
1Y
195.85%
3Y*
7.82%
5Y*
-32.76%
10Y*
-13.53%

HIBL

1D
-2.25%
1M
38.56%
YTD
96.27%
6M
98.56%
1Y
279.13%
3Y*
62.03%
5Y*
11.57%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

LABU vs. HIBL - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
LABU
Direxion Daily S&P Biotech Bull 3x Shares
3.80%79.17%-26.02%-13.41%-80.36%-64.15%74.66%53.10%
HIBL
Direxion Daily S&P 500 High Beta Bull 3X Shares
96.27%60.38%-0.40%81.02%-68.24%129.14%-24.96%21.45%

Correlation

The correlation between LABU and HIBL is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.49

Correlation (3Y)
Calculated over the trailing 3-year period

0.57

Correlation (5Y)
Calculated over the trailing 5-year period

0.61

Correlation (All Time)
Calculated using the full available price history since Nov 8, 2019

0.55

The correlation between LABU and HIBL shifts across timeframes, from 0.49 (1 year) to 0.61 (5 years), reflecting how their relationship changes across market environments.

LABU vs. HIBL - Sectors Allocation Comparison


Sectors
LABU
HIBL

Healthcare

99.8%
2.9%

Financial Services

0.2%
12.5%

Basic Materials

0.0%
4.6%

Communication Services

-

3.7%

Consumer Cyclical

-

12.9%

Consumer Defensive

-

0.6%

Energy

-

2.2%

Industrials

-

11.7%

Real Estate

-

-

Technology

-

45.8%

Utilities

-

3.2%

Healthcare

LABU
99.8%
HIBL
2.9%

Financial Services

LABU
0.2%
HIBL
12.5%

Basic Materials

LABU
0.0%
HIBL
4.6%

Communication Services

LABU

-

HIBL
3.7%

Consumer Cyclical

LABU

-

HIBL
12.9%

Consumer Defensive

LABU

-

HIBL
0.6%

Energy

LABU

-

HIBL
2.2%

Industrials

LABU

-

HIBL
11.7%

Real Estate

LABU

-

HIBL

-

Technology

LABU

-

HIBL
45.8%

Utilities

LABU

-

HIBL
3.2%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LABU vs. HIBL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LABU
LABU Risk / Return Rank: 7575
Overall Rank
LABU Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
LABU Sortino Ratio Rank: 6161
Sortino Ratio Rank
LABU Omega Ratio Rank: 5555
Omega Ratio Rank
LABU Calmar Ratio Rank: 9292
Calmar Ratio Rank
LABU Martin Ratio Rank: 8787
Martin Ratio Rank

HIBL
HIBL Risk / Return Rank: 8989
Overall Rank
HIBL Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
HIBL Sortino Ratio Rank: 8080
Sortino Ratio Rank
HIBL Omega Ratio Rank: 7777
Omega Ratio Rank
HIBL Calmar Ratio Rank: 9696
Calmar Ratio Rank
HIBL Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LABU vs. HIBL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and Direxion Daily S&P 500 High Beta Bull 3X Shares (HIBL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LABUHIBLDifference
Sharpe ratioReturn per unit of total volatility

-1.66

Sortino ratioReturn per unit of downside risk

-0.68

Omega ratioGain probability vs. loss probability

1.35

1.47

-0.12

Calmar ratioReturn relative to maximum drawdown

6.42

8.96

-2.53

Martin ratioReturn relative to average drawdown

18.77

32.84

-14.07

LABU vs. HIBL - Sharpe Ratio Comparison

The current LABU Sharpe Ratio is 2.60, which is lower than the HIBL Sharpe Ratio of 4.26. The chart below compares the historical Sharpe Ratios of LABU and HIBL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


LABUHIBLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.60

4.26

-1.66

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.34

0.14

-0.49

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.24

0.24

-0.48

Drawdowns

LABU vs. HIBL - Drawdown Comparison

The maximum LABU drawdown since its inception was -99.18%, which is greater than HIBL's maximum drawdown of -88.27%. Use the drawdown chart below to compare losses from any high point for LABU and HIBL.


Loading charts...

Drawdown Indicators


LABUHIBLDifference

Max Drawdown

Largest peak-to-trough decline

-99.18%

-88.27%

-10.91%

Max Drawdown (1Y)

Largest decline over 1 year

-30.70%

-31.39%

+0.69%

Max Drawdown (3Y)

Largest decline over 3 years

-78.30%

-69.66%

-8.64%

Max Drawdown (5Y)

Largest decline over 5 years

-97.59%

-81.58%

-16.01%

Max Drawdown (10Y)

Largest decline over 10 years

-98.96%

Current Drawdown

Current decline from peak

-96.34%

-2.25%

-94.09%

Average Drawdown

Average peak-to-trough decline

-81.68%

-44.20%

-37.48%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.48%

8.55%

+1.93%

Volatility

LABU vs. HIBL - Volatility Comparison

Direxion Daily S&P Biotech Bull 3x Shares (LABU) has a higher volatility of 27.83% compared to Direxion Daily S&P 500 High Beta Bull 3X Shares (HIBL) at 21.25%. This indicates that LABU's price experiences larger fluctuations and is considered to be riskier than HIBL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LABUHIBLDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.83%

21.25%

+6.58%

Volatility (6M)

Calculated over the trailing 6-month period

59.70%

50.46%

+9.24%

Volatility (1Y)

Calculated over the trailing 1-year period

75.91%

66.16%

+9.75%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

95.58%

82.16%

+13.42%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

95.42%

91.89%

+3.53%

LABU vs. HIBL - Expense Ratio Comparison

Both LABU and HIBL have an expense ratio of 1.12%.


Dividends

LABU vs. HIBL - Dividend Comparison

LABU's dividend yield for the trailing twelve months is around 0.74%, less than HIBL's 1.18% yield.


PositionTTM202520242023202220212020201920182017
HIBL
Direxion Daily S&P 500 High Beta Bull 3X Shares
1.18%2.43%0.82%0.69%0.00%0.06%0.19%0.19%0.00%0.00%
LABU
Direxion Daily S&P Biotech Bull 3x Shares
0.74%0.84%0.35%0.35%0.00%0.00%0.00%0.28%0.64%0.17%

Frequently Asked Questions


LABU and HIBL have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LABU has higher volatility (27.83%) compared to HIBL (21.25%). In terms of maximum drawdown, LABU dropped -99.18% vs HIBL's -88.27%.

On 5-year performance, HIBL leads with 11.57% vs -32.76% for LABU. Both ETFs have the same 1.12% expense ratio. On volatility, HIBL has been the lower-risk option at 21.25%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, HIBL has performed better with a 11.57% return vs -32.76%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

LABU and HIBL have the same expense ratio: 1.12% per year.

HIBL has the higher dividend yield at 1.18%, compared with 0.74% for LABU.

LABU tracks S&P Biotechnology Select Industry Index (300%), while HIBL tracks S&P 500 High Beta Index (300%).

HIBL currently has the higher Sharpe Ratio (4.26 vs 2.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LABU and HIBL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer